Scientists Unveil Potential First-of-Its-Kind Treatment for Deadly Fatty Liver Disease

[bonami2]

Quote

Published in The Lancet, the study reports that the drug, known as ION224, blocks a liver enzyme called DGAT2. This enzyme is essential for the liver’s process of producing and storing fat. Inhibiting it reduces both fat accumulation and inflammation, the two main contributors to liver damage in MASH.

“This study marks a pivotal advance in the fight against MASH,” said Rohit Loomba, MD, principal investigator of the study and chief of the Division of Gastroenterology and Hepatology at UC San Diego School of Medicine. “By blocking DGAT2, we’re interrupting the disease process at its root cause, stopping fat accumulation and inflammation right in the liver.”

Scientists Unveil Potential First-of-Its-Kind Treatment for Deadly Fatty Liver Disease

SCITECHDAILY.COM

---

A new investigational treatment targets the root cause of a life-threatening liver condition connected to obesity and diabetes, offering hope for millions of patients. Scientists at the University of California...

 

Edited September 15, 2025 by bonami2

[CoolGTX]

thanks for the info; that is something that I have not seen elsewhere

[bonami2]

12 hours ago, CoolGTX said:

thanks for the info; that is something that I have not seen elsewhere

 

Trying to find stuff that no one talk about is the reason i shared this happy to know am not the only one happy to see those discovery.

Lots of thing on Alzheimer recently too